We’ve been curious about Celgene’s activity in precision medicine for some time. We’ve posted blog posts here, here and here proposing that Celgene’s activities are indicative of a precision medicine push. As a supplement, this weeks CotW is a network graph of Celgene’s clinical trial activity, biomarker usage and corresponding disease areas.
